Back
uniQure NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Sell
11
QURE
uniQure NV
Last Price:
5.46
Seasonality Move:
11.25%
Sell
27
PRQR
ProQR Therapeutics NV
Last Price:
1.78
Seasonality Move:
-2.94%
Sell
11
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy, Sell or Hold?
- The current uniQure NV [QURE] share price is $5.65. The Score for QURE is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- QURE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.79. The Score for PRQR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
QURE Stock Price Chart
What is uniQure NV's stock price today?
-
The uniQure NV share price today is $5.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QURE is experiencing selling pressure, which indicates risk of future bearish movement.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight buying pressure.
QURE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 42.92 | Sell |
Chaikin Money Flow: | -389324 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.43 - 6.45) | Sell |
Bollinger Bands (100): | (4.49 - 7.31) | Sell |
PRQR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 34.88 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.83 - 2.09) | Sell |
Bollinger Bands (100): | (1.74 - 2.02) | Sell |
QURE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.55 | Buy |
20-day SMA: | 5.74 | Sell |
50-day SMA: | 6.89 | Sell |
200-day SMA: | 5.86 | Sell |
8-day EMA: | 5.61 | Buy |
20-day EMA: | 5.83 | Sell |
50-day EMA: | 6.15 | Sell |
200-day EMA: | 6.73 | Sell |
PRQR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.83 | Sell |
20-day SMA: | 1.92 | Sell |
50-day SMA: | 1.92 | Sell |
200-day SMA: | 2 | Sell |
8-day EMA: | 1.83 | Sell |
20-day EMA: | 1.89 | Sell |
50-day EMA: | 1.91 | Sell |
200-day EMA: | 1.91 | Sell |
uniQure NV Earnings Growth & QURE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.44 per share, an increase this year of $2.09 per share, and an increase next year of $1.38 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
uniQure NV Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProQR Therapeutics NV Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |